ScholarIQanswers from OpenAlex
Contemporary Clinical Trials
JournalCitation impact & published research
Contemporary Clinical Trials is a journal indexed in ScholarIQ from OpenAlex.
What is the OpenAlex record for Contemporary Clinical Trials?
ScholarIQopenalex
The OpenAlex for Contemporary Clinical Trials is on the source record.
What are the most-cited papers on Contemporary Clinical Trials?
ScholarIQmost cited works
Comparison of methods for estimating the intraclass correlation coefficient for binary responses in cancer prevention cluster randomized trials
Sheng Wu, Catherine M. Crespi, Weng Kee Wong
An analysis of U.S. practices of paying research participants
Christine Grady, Neal W. Dickert, Tom Jawetz, Gary Gensler, Ezekiel J. Emanuel
The Anorexia Nervosa Genetics Initiative (ANGI): Overview and methods
Laura M. Thornton, Melissa A. Munn‐Chernoff, Jessica H. Baker, Anders Juréus, Richard Parker, Anjali K. Henders, Janne Tidselbak Larsen, Liselotte Petersen, Hunna J. Watson, Zeynep Yılmaz, Katherine M. Kirk, Scott D. Gordon, Virpi Leppä, Felicity C. Martin, David C. Whiteman, Catherine M. Olsen, Thomas Werge, Nancy L. Pedersen, Walter H. Kaye, Andrew W. Bergen, Katherine A. Halmi, Michael Strober, Allan S. Kaplan, D. Blake Woodside, James E. Mitchell, Craig L. Johnson, Harry Brandt, Steven Crawford, L. John Horwood, Joseph M. Boden, John F. Pearson, Laramie E. Duncan, Jakob Grove, Manuel Mattheisen, Jennifer Jordan, Martin A. Kennedy, Andreas Birgegård, Paul Lichtenstein, Claes Norring, Tracey Wade, Grant W. Montgomery, Nicholas G. Martin, Mikael Landén, Preben Bo Mortensen, Patrick F. Sullivan, Cynthia M. Bulik
A phase 2, adaptive randomized, double-blind, placebo-controlled, multicenter, 52-week study of HM15211 in patients with biopsy-confirmed non-alcoholic steatohepatitis – Study design and rationale of HM-TRIA-201 study
Manal F. Abdelmalek, Ayako Suzuki, Willian Sanchez, Eric Lawitz, Claudia Filozof, Hyung-Jin Cho, Eunhye Baek, JaeDuk Choi, Seung Jae Baek
The Irritable Bowel Syndrome Outcome Study (IBSOS): Rationale and design of a randomized, placebo-controlled trial with 12month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome
Jeffrey M. Lackner, Laurie Keefer, James Jaccard, Rebecca Firth, Darren M. Brenner, Jason Bratten, Laura J. Dunlap, Chang‐Xing Ma, Mark Byroads